Floatz logo

LAC VACCINUM

Milk Intolerance

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnementother_biologicalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Milk Intolerance cohort.

Asset / SponsorPhaseRating
Rp-G28
Ritter Pharmaceuticals, Inc.
Phase 3A
Lactase
University of Pecs
Phase 3BB
A2 beta-casein
Purdue University
N/AD
Streptococcus thermophilus DSM 24731
Société des Produits Nestlé (SPN)
N/AD
Alverine
University of Pecs
N/AD

View all 9 →

Same molecule, other indications

LAC VACCINUM is also rated in:

Alzheimer diseaseDormant
C
Indicative ·
37 / 100
View asset →
obesity disorderDormant
D
Indicative ·
30 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →